載入...
‘A phase II study of oral uracil/ftorafur (UFT®) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer’
This phase II trial was performed to evaluate the efficacy and tolerability of a new combination of Uracil/Ftorafur (UFT®)/leucovorin (LV) and oxaliplatin in patients (pts) with metastatic colorectal cancer (MCRC) who had not received prior chemotherapy for metastatic disease. Between February 2002...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group
2006
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2361076/ https://ncbi.nlm.nih.gov/pubmed/16404362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602913 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|